{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:27:01Z","timestamp":1775852821233,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.1097\/qai.0000000000000060","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T12:08:06Z","timestamp":1384949286000},"page":"438-446","source":"Crossref","is-referenced-by-count":17,"title":["High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa"],"prefix":"10.1097","volume":"65","author":[{"given":"Kogieleum","family":"Naidoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quarraisha Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambika","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasavan","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia K.","family":"Mchunu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Frohlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farina","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Upfold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kocheleff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Abdool Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-8-20210131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(09)60916-8","article-title":". HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.","volume":"374","author":"Abdool Karim","year":"2009","journal-title":"Lancet"},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QAD.0b013e3282f2ef43","article-title":". High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study.","volume":"22","author":"Barnighausen","year":"2008","journal-title":"AIDS"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":". Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-8-20210131","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1371\/journal.pone.0000826","article-title":". Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.","volume":"2","author":"Miranda","year":"2007","journal-title":"PloS One"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":". Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cis203","article-title":"Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5588\/ijtld.10.0483","article-title":". Antiretroviral therapy and the control of HIV-associated tuberculosis.","volume":"15","author":"Lawn","year":"2011","journal-title":"Will ART do it Int J Tuberc Lung Dis"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.04.00109303","article-title":". Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy.","volume":"24","author":"Girardi","year":"2004","journal-title":"Eur Respir J"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":". Timing of initiation of antiretroviral drugs during tuberculosis therapy.","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":". Integration of antiretroviral therapy with tuberculosis treatment.","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":". Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.","volume":"365","author":"Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":". Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.","volume":"365","author":"Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-8-20210131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":". Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201004-0598OC","article-title":". Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township.","volume":"182","author":"Middelkoop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-8-20210131","doi-asserted-by":"crossref","first-page":"758350","DOI":"10.1155\/2011\/758350","article-title":". Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.","volume":"2011","author":"Worodria","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"suppl 1","key":"R23-8-20210131","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":". Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.","volume":"196","author":"McIlleron","year":"2007","journal-title":"J Infect Dis"},{"key":"R24-8-20210131","first-page":"862","article-title":". HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.","volume":"13","author":"Martinson","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"R25-8-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":". Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R26-8-20210131","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":". Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.","volume":"20","author":"Bonnet","year":"2006","journal-title":"AIDS"},{"key":"R27-8-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R28-8-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":". Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R29-8-20210131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/605500","article-title":". Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.","volume":"49","author":"Castelnuovo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R30-8-20210131","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":". Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"R31-8-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/QAI.0b013e3181ab6d8b","article-title":". CD4 response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.","volume":"52","author":"Chi","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-8-20210131","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAI.0b013e31819906d3","article-title":". Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: the Asia Pacific HIV Observational Database (APHOD).","volume":"50","author":"Egger","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-8-20210131","first-page":"1178","article-title":". Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis.","volume":"7","author":"Gonzalez","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"R34-8-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAI.0b013e3181b62933","article-title":". Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.","volume":"52","author":"Moore","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-8-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-6405-5-23","article-title":". Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance.","volume":"5","author":"Nakanjako","year":"2008","journal-title":"AIDS Res Ther"},{"key":"R36-8-20210131","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/QAD.0b013e3283121ca9","article-title":". Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.","volume":"22","author":"Nash","year":"2008","journal-title":"AIDS"},{"key":"R37-8-20210131","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/498308","article-title":"Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries.","volume":"41","author":"Lawn","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R38-8-20210131","first-page":"318","article-title":". Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.","volume":"14","author":"Dembele","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R39-8-20210131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":". Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R40-8-20210131","doi-asserted-by":"crossref","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","article-title":". Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.","volume":"5","author":"Hermans","year":"2010","journal-title":"PloS One"},{"key":"R41-8-20210131","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0040022","article-title":". Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease.","volume":"4","author":"Corbett","year":"2007","journal-title":"PLoS Med"},{"key":"R42-8-20210131","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/429825","article-title":". High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.","volume":"40","author":"Mtei","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R43-8-20210131","doi-asserted-by":"crossref","first-page":"e1000296","DOI":"10.1371\/journal.pmed.1000296","article-title":". The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.","volume":"7","author":"Cohen","year":"2010","journal-title":"PLoS Med"},{"key":"R44-8-20210131","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/QAD.0b013e3282eea47f","article-title":". Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study.","volume":"21","author":"Martinson","year":"2007","journal-title":"AIDS"},{"key":"R45-8-20210131","doi-asserted-by":"crossref","first-page":"e55824","DOI":"10.1371\/journal.pone.0055824","article-title":". Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"key":"R46-8-20210131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1086\/595985","article-title":". Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy.","volume":"199","author":"Manabe","year":"2009","journal-title":"J Infect Dis"},{"key":"R47-8-20210131","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.ijid.2009.05.016","article-title":". Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review.","volume":"14","author":"Leone","year":"2010","journal-title":"Int J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000000060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:50Z","timestamp":1620970610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201404010-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000000060","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}